Get the Stockscreener App
54.84
10.23%
5.09
After Hours:
54.79
-0.05
-0.09%
Hinge Health Inc stock is traded at $54.84, with a volume of 5.10M.
It is up +10.23% in the last 24 hours and up +39.93% over the past month.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
See More
Previous Close:
$49.75
Open:
$52.5
24h Volume:
5.10M
Relative Volume:
3.86
Market Cap:
$4.24B
Revenue:
$587.86M
Net Income/Loss:
$-425.10M
P/E Ratio:
-9.6363
EPS:
-5.691
Net Cash Flow:
-
1W Performance:
+24.66%
1M Performance:
+39.93%
6M Performance:
+24.52%
1Y Performance:
+0.00%
1-Day Range:
$48.08
$55.79
1-Week Range:
$43.18
$55.79
52-Week Range:
$30.08
$62.18
Hinge Health Inc Stock (HNGE) Company Profile
Name
Hinge Health Inc
Sector
Industry
Phone
415-689-8429
Address
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
54.84 | 3.85B | 587.86M | -425.10M | 0 | -5.691 |
VEEV
Veeva Systems Inc
|
167.35 | 27.94B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.74 | 9.98B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
53.50 | 9.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
83.25 | 6.98B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.69 | 4.76B | 637.78M | 239.40M | 307.21M | 1.1909 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Wells Fargo | Overweight |
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-14-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jun-16-25 | Initiated | Barclays | Overweight |
| Jun-16-25 | Initiated | BofA Securities | Buy |
| Jun-16-25 | Initiated | Canaccord Genuity | Buy |
| Jun-16-25 | Initiated | Evercore ISI | Outperform |
| Jun-16-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-25 | Initiated | Morgan Stanley | Overweight |
| Jun-16-25 | Initiated | Needham | Buy |
| Jun-16-25 | Initiated | Piper Sandler | Overweight |
| Jun-16-25 | Initiated | RBC Capital Mkts | Outperform |
| Jun-16-25 | Initiated | Raymond James | Outperform |
| Jun-16-25 | Initiated | Stifel | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-16-25 | Initiated | William Blair | Outperform |
View All
Hinge Health Inc Stock (HNGE) Latest News
HNGE (HNGE) director files to sell 150,000 shares; prior 10b5-1 sales noted - Stock Titan
HNGE (HNGE) Rule 144: 300,001 RSUs listed; insiders sold 250,shares under 10b5-1 - Stock Titan
Hinge Health (NYSE:HNGE) Given New $67.00 Price Target at Stifel Nicolaus - MarketBeat
HNGE Stock Up on Q1 Earnings & Revenue Beat, 2026 Outlook Improved - Yahoo! Finance Canada
Hinge Health (NYSE:HNGE) Price Target Raised to $80.00 - MarketBeat
Hinge Health (NYSE:HNGE) Price Target Raised to $80.00 at Wells Fargo & Company - MarketBeat
Hinge Health (NYSE:HNGE) Given New $63.00 Price Target at Needham & Company LLC - MarketBeat
Canaccord raises Hinge Health stock price target on margin strength - Investing.com
Canaccord raises Hinge Health stock price target on margin strength By Investing.com - Investing.com Canada
Citizens raises Hinge Health stock price target on strong Q1 results - Investing.com Nigeria
Hinge Health forecasts $798M-$804M 2026 revenue while launching FDA-cleared Enso migraine program - MSN
Hinge Health Q1 2026 Earnings Call Transcript - MarketBeat
Hinge Health Earnings Call Signals Profitable Growth - TipRanks
Hinge Health Q1 2026 slides: 47% revenue growth, margins hit 25% - Investing.com
Hinge Health (HNGE) Q1 2026 Earnings Transcript - AOL.com
Earnings call transcript: Hinge Health beats Q1 2026 earnings expectations - Investing.com
Hinge Health surges on earnings beat and raised outlook By Investing.com - Investing.com Canada
Hinge Health surges on earnings beat and raised outlook - Investing.com
Hinge Health Lifts 2026 Outlook After Record Quarter - TipRanks
Hinge Health Momentum Builds as Digital Care Demand Accelerates - Kalkine Media
Why Hinge Health Stock Is Suddenly Sliding Now - TipRanks
(HNGE) Hinge Health, Inc. Expects Q2 Revenue Range $194.0M$196.0M - marketscreener.com
Earnings Flash (HNGE) Hinge Health, Inc. Posts Q1 Adjusted EPS $0.45 per Share, vs. FactSet Est of $0.40 - marketscreener.com
Hinge Health, Inc. (HNGE) Tops Q1 EPS by 33c, provides guidance - StreetInsider
Hinge Health reports record first quarter 2026 financial results - Business Wire
Hinge Health (NYSE:HNGE) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Hinge Health earnings up next: Can moats offset growth slowdown? By Investing.com - Investing.com South Africa
Hinge Health earnings up next: Can moats offset growth slowdown? - Investing.com UK
Hinge Health (NYSE:HNGE) Trading 6.3% HigherTime to Buy? - MarketBeat
Hinge Health (HNGE) president relinquishes shares to cover RSU tax withholding - Stock Titan
Hinge Health (HNGE) CFO uses 4,614 shares to cover tax withholding - Stock Titan
Hinge Health stock sees RS rating jump ahead of earnings - MSN
Barclays Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $52 - Moomoo
Why Hinge Health Shares Are Surging Before Earnings - TipRanks
A Quick Look at Today's Ratings for Hinge Health(HNGE.US), With a Forecast Between $45 to $72 - Moomoo
Mutual Advisors LLC Makes New $6.04 Million Investment in Hinge Health Inc. $HNGE - MarketBeat
Hinge Health (NYSE:HNGE) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Ionis Pharmaceuticals (IONS) and GE Healthcare Technologies Inc (GEHC) - The Globe and Mail
Is It Time To Reconsider Hinge Health (HNGE) After Recent Digital Care Headlines? - Sahm
Hinge Health Buy Rating Reiterated on Growth Momentum and Migraine Expansion, Price Target Maintained at $72 - TipRanks
Hinge Health Inc. $HNGE Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Earnings Preview: Hinge Health to Report Financial Results Post-market on May 05 - Moomoo
Hinge Health Launches Comprehensive Migraine Care Program - Fitt Insider
Here's why you should add Hinge Health stock to your portfolio now - MSN
Hinge Health launches comprehensive Migraine Care Program - The National Law Review
Hinge Health announces $250M buyback program - MSN
Is Hinge Health Stock Worth Watching Right Now - Kalkine Media
HANSAINVEST holds 1.48M shares in Hinge Health (HNGE) per 13G filing - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Purchases 149,777 Shares of Hinge Health Inc. $HNGE - MarketBeat
Whale Rock exits Hinge Health, adds Macom, pares Celestica, among Q4 trades - MSN
Citizens reiterates Hinge Health stock rating on digital health moat By Investing.com - Investing.com Australia
Hinge Health Inc Stock (HNGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.49%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):